Notably, Om-PDRN (20 mg) injection at pain site alleviated mechanical allodynia and reduced glial fibrillary acidic protein (GFAP) expression, which is predominantly associated with neuro-inflammatory states, on spinal nerve ligation (SNL)- and chronic post-ischemia-induced pain models. This evidence concerns the gene GFAP and ischemia.